N-Acetyl Cysteine and Improved Verbal Memory

Doses used in studies

Time to effect

Median: 5.6 months · IQR 5.6 months–5.6 months · Range 5.6 months–5.6 months — Reported in 1 of 1 study

Safety in these studies

adverse eventsNo significant difference
N-acetylcysteine was generally well-tolerated, with adverse events comparable between groups.
from: Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergo
Overall tolerabilityReported
N-acetylcysteine was generally well-tolerated, with adverse events comparable between groups.
from: Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergo

1 of 1 paper

Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergoing exercise-based cardiac rehabilitation program: a randomized controlled trial.